Advanced search
Publication Cover
Journal of Medical Economics Volume 14, 2011 - Issue 1
Submit an article Journal homepage
1,156
Views
63
CrossRef citations to date
0
Altmetric
Original Article

Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy

N.L. Edwards Department of Rheumatology, University of Florida, Gainesville, FL, USA
,
J.S. Sundy Department of Medicine, Duke University School of Medicine, Durham, NC, USA
,
A. Forsythe Savient Pharmaceuticals, Inc., East Brunswick, NJ, USA
,
S. Blume United BioSource Corporation, Center for Health Outcomes Research, Bethesda, MD, USA
,
F. Pan United BioSource Corporation, Center for Health Outcomes Research, Bethesda, MD, USACorrespondence[email protected]
&
M.A. Becker Department of Medicine, University of Chicago, Chicago, IL, USA
Pages 10-15 | Accepted 15 Nov 2010, Published online: 07 Dec 2010

References

  • Savient Pharmaceuticals Inc. KRYSTEXXA™ (pegloticase) for intravenous infusion BLA No. 125293. Silver Spring, MD: U.S. Food and Drug Administration, 2009 http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisDrugsAdvisoryCommittee/UCM165814.pdf.August 30, 2010
  • Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42
  • Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35
  • Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999:1-203
  • Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising? J Rheumatol 2002;29:2403-2406
  • Edwards NL. Treatment-failure gout: a moving target. Arthritis Rheum 2008;58:2587-2590
  • Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-799
  • Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol 2007;3:443-449
  • Wallace KL, Riedel AA, Joseph-Ridge N, et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-1587
  • Wu EQ, Patel PA, Yu AP, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008;14:164-175
  • Roubenoff R. Gout and hyperuricemia. Rheum Dis Clin North Am 1990;16:539-550
  • Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health 2007;10:231-237
  • Brook RA, Kleinman NL, Patel PA, et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006;22:1381-1389
  • Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009;36:1041-1048
  • Chohan S, Becker MA. Update on emerging urate-lowering therapies. Curr Opin Rheumatol 2009;21:143-149. Review. Erratum in: Curr Opin Rheumatol. 2010 Jan;2022(2011):2106
  • Ware JE, Snow KK, Kosinski MK, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993
  • Burton W, Morrison A, Maclean R, et al. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006;56:18-27
  • Chorus AM, Boonen A, Miedema HS, et al. Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis 2002;61:693-699
  • Chorus AM, Miedema HS, Wevers CW, et al. Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:1025-1032
  • Mancuso CA, Paget SA, Charlson ME. Adaptations made by rheumatoid arthritis patients to continue working: a pilot study of workplace challenges and successful adaptations. Arthritis Care Res 2000;13:89-99

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.